SCHEMBL1692213

SCHEMBL1692213

Cc1sc(NC(=O)C(CC(=O)O)NC(=O)OCC2c3ccccc3-c3ccccc32)c(C(=O)c2ccc(Cl)c(C(C)(C)C)c2)c1C

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CASP3 P42574 4/20 0.39
▸ MDM4 O15151 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ KMT2A Q03164 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ MAPT P10636 4/20 0.36
▸ HPGD P15428 4/20 0.36
▸ LMNA P02545 2/20 0.36
▸ PLA2G1B P04054 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ ATG4B Q9Y4P1 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ MDM2 Q00987 2/20 0.35
▸ PTPN1 P18031 1/20 0.35
▸ SLC17A5 Q9NRA2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15281424 0.89 CASP3 (0.44) CASP3MDM4TP53KMT2AALDH1A1
SCHEMBL872752 0.89 CASP3 (0.44) CASP3MDM4TP53KMT2AALDH1A1
SCHEMBL23728631 0.89 CASP3 (0.44) CASP3MDM4TP53KMT2AALDH1A1
SCHEMBL18551519 0.85 MDM2 (0.43) CASP3MDM4TP53KMT2AALDH1A1
SCHEMBL31498720 0.84 MDM2 (0.36) CASP3MDM4TP53MDM2PTPN1
SCHEMBL2641803 0.82 BRD4 (0.41) MDM4TP53ALDH1A1MAPTHPGD
SCHEMBL15182047 0.82 BRD4 (0.41) MDM4TP53ALDH1A1MAPTHPGD
SCHEMBL15106634 0.82 BRD4 (0.41) MDM4TP53ALDH1A1MAPTHPGD
SCHEMBL30410248 0.82 ALDH1A1 (0.42) CASP3MDM4TP53ALDH1A1MAPT
SCHEMBL25695323 0.82 ALDH1A1 (0.42) CASP3MDM4TP53ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2569434-A2 COMPOSITIONS AND METHODS FOR TREATING LEUKEMIA Dana-Farber Cancer Institute, Inc. (US) 2013-03-20 — — EP disclosed
EP-2569429-A1 COMPOSITIONS AND METHODS FOR MODULATING METABOLISM Dana-Farber Cancer Institute, Inc. (US) 2013-03-20 — — EP disclosed
WO-2011143651-A1 COMPOSITIONS AND METHODS FOR MODULATING METABOLISM DANA-FARBER CANCER INSTITUTE, INC. (US) 2011-11-17 — — WO disclosed
WO-2011143660-A2 COMPOSITIONS AND METHODS FOR TREATING LEUKEMIA DANA-FARBER CANCER INSTITUTE, INC. (US) 2011-11-17 — — WO disclosed
Send feedback